Fluidigm Corporation (FLDM)

Etorro trading 970x250
Fluidigm Corporation (FLDM) Logo

About Fluidigm Corporation

Fluidigm Corporation creates, manufactures, and markets technologies and life sciences tools worldwide. It offers analytical systems comprising Helios, a CyTOF system, Hyperion imaging system, Hyperion tissue imager, and flow conductor; and assays and reagents, including Maxpar reagents and Maxpar human immune monitoring panel kit and workflow., as well as Maxpar direct immune profiling assays and IMC panel kits for immuno-oncology. The company also provides preparatory instruments, such as access array and Juno systems; and analytical instruments comprising Biomark HD system and EP1 system. In addition, it offers integrated fluidic circuits (IFCs), such as library preparation IFCs, Juno genotyping IFC, dynamic array IFCs, digital array IFCs, and Flex Six IFC; and assays and reagents, including Advanta RNA-Seq NGS library prep kits, delta gene and SNP type assays, access array target-specific primers and targeted sequencing prep primers, and targeted DNA Seq library assays. Further, the company offers single cell microfluidics that comprise C1 system, Polaris system, C1 IFCs, and Polaris IFC. Fluidigm Corporation sells its products to academic research institutions; translational research and medicine centers; cancer centers; clinical research laboratories; biopharmaceutical, biotechnology, and plant and animal research companies; and contract research organizations. The company was formerly known as Mycometrix Corporation and changed its name to Fluidigm Corporation in April 2001. Fluidigm Corporation was founded in 1999 and is headquartered in South San Francisco, California. Address: 2 Tower Place, South San Francisco, CA, United States, 94080

Fluidigm Corporation News and around…

Latest news about Fluidigm Corporation (FLDM) common stock and company :

Fluidigm 2021 IMC Summit Focuses on ‘Uncovering Spatial Biology’
18 Oct, 2021 Yahoo! Finance

Latest Imaging Mass Cytometry Discoveries in Infectious Disease, Immuno-Oncology and the Tumor Microenvironment from Expert Users of the TechnologySOUTH SAN FRANCISCO, Calif., Oct. 18, 2021 (GLOBE NEWSWIRE) -- Fluidigm Corporation (NASDAQ:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive health insight, today announced the agenda for its IMC™ Summit: Uncovering Spatial Biology. The October 21 virtual event highlights research insights attained

Fluidigm Announces New Co-Marketing Program under Collaboration Agreement with Visiopharm, Offering AI-Based Image Analysis Software
12 Oct, 2021 Yahoo! Finance

Native Reading of Hyperion Imaging System Data Files on the Visiopharm Platform to Streamline Data Analysis for ResearchersSOUTH SAN FRANCISCO, Calif., Oct. 12, 2021 (GLOBE NEWSWIRE) -- Fluidigm Corporation (NASDAQ:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive health insight, today announced a new co-marketing program to offer Visiopharm® image analysis software for faster and more streamlined analysis of data acquired through Imaging Mass

Fluidigm Announces Collaboration Agreement with Karolinska Institutet to Accelerate Customer Adoption of New CyTOF XT
28 Sep, 2021 FinancialContent

Department of Women’s and Children’s Health to Work with Fluidigm on CyTOF Research Applications, Product Development

Fluidigm to Participate in the Cantor Virtual Global Healthcare Conference
02 Sep, 2021 FinancialContent
Return on Capital Employed Insights for Fluidigm
31 Aug, 2021 FinancialContent

After pulling data from Benzinga Pro it seems like during Q2, Fluidigm's (NASDAQ:FLDM) reported sales totaled $31.02 million. Despite a ...

CyTOF and Maxpar Direct Technologies Utilized in Study Characterizing Immune and Inflammatory Responses in Pregnant Women Infected with SARS-CoV-2
31 Aug, 2021 FinancialContent
Investors in Fluidigm (NASDAQ:FLDM) have unfortunately lost 25% over the last five years
10 Aug, 2021 Yahoo! Finance

While not a mind-blowing move, it is good to see that the Fluidigm Corporation ( NASDAQ:FLDM ) share price has gained...

Fluidigm to Participate in UBS Genomics 2.0 and MedTech Innovations Summit
09 Aug, 2021 FinancialContent
Fluidigm Q2 Earnings Ahead Of Street Expectations, But Sees Lower Revenues From COVID-19 Products
06 Aug, 2021 FinancialContent

Fluidigm Corp's(NASDAQ: FLDM)second-quarter revenues grew 19% Y/Y to $31 million, edging out analysts' average ...

12 Health Care Stocks Moving In Thursday's After-Market Session
05 Aug, 2021 FinancialContent

Gainers Sensus Healthcare (NASDAQ:SRTS) shares moved upwards by 18.07% to $4.18 during Thursday's after-market session. This ...

Fluidigm Announces Second Quarter 2021 Financial Results with Total Revenue of $31.0 Million
05 Aug, 2021 FinancialContent
Ultivue Announces Co-Marketing Agreement with Fluidigm for Biomarker Imaging Solutions for Precision Medicine
05 Aug, 2021 FinancialContent

Ultivue, Inc. and Fluidigm Corporation (Nasdaq:FLDM) today announced a co-marketing agreement in which the companies will offer customers a comprehensive portfolio of workflow solutions for biomarker discovery and drug development.

Fluidigm Announces Collaboration Agreement with Imaging CRO ImaBiotech to Increase Biopharma Access to Imaging Mass Cytometry
05 Aug, 2021 FinancialContent

Collaboration Focusing on Advancing CRO Capabilities in Drug Development Utilizing the Hyperion Imaging System

Fluidigm Announces Co-Marketing Agreement with Ultivue for Biomarker Imaging Solutions for Precision Medicine
05 Aug, 2021 FinancialContent

Objective of Agreement is Comprehensive Portfolio for Biomarker Discovery and Drug Development

Unusual Options Activity Insight: Fluidigm
04 Aug, 2021 FinancialContent

Shares of Fluidigm (NASDAQ:FLDM) saw some unusual options activity on Wednesday. Following the unusual option alert, the stock price ...

62 Biggest Movers From Yesterday
29 Jul, 2021 FinancialContent

Gainers Flora Growth Corp. (NASDAQ: FLGC) surged 63.1% to close at $8.27. The Miami-based cannabis producer confirmed Tuesday it ...

Notable Wednesday Option Activity: TNL, FLDM, LVS
28 Jul, 2021 FinancialContent

Among the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in Travel + Leisure Co (TNL), where a total of 7,002 contracts have traded so far, representing approximately 700,200 underlying shares. That amounts to about 125.4% of TNL's average daily trading volume over the past month of 558,565 shares..

50 Stocks Moving In Wednesday's Mid-Day Session
28 Jul, 2021 FinancialContent

Gainers Infinity Pharmaceuticals Inc. (NASDAQ: INFI) shares jumped 59.9% to $2.43. Infinity Pharmaceuticals shares tumbled over ...

Interesting FLDM Put And Call Options For September 17th
28 Jul, 2021 FinancialContent

Investors in Fluidigm Corp (FLDM) saw new options begin trading this week, for the September 17th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the FLDM options chain for the new September 17th contracts and identified one put and one call contract of particular interest.

Fluidigm Stock Shoots Higher On Bloomberg Report Of Exploring Potential Sale
28 Jul, 2021 FinancialContent

Fluidigm Corp(NASDAQ: FLDM) stock is trading higher in the premarket on a report that the Company is considering a ...

First Week of FLDM February 2022 Options Trading
20 Jul, 2021 FinancialContent

Investors in Fluidigm Corp (FLDM) saw new options become available this week, for the February 2022 expiration. One of the key data points that goes into the price an option buyer is willing to pay, is the time value, so with 213 days until expiration the newly available contracts represent a possible opportunity for sellers of puts or calls to achieve a higher premium than would be available for the contracts with a closer expiration..

Fluidigm Announces Conference Call and Webcast of Second Quarter 2021 Financial Results
08 Jul, 2021 FinancialContent
Analysts Predict 13% Gains Ahead For OMFS
18 Jun, 2021 FinancialContent

Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. For the Invesco Russell 2000—Dynamic Multifactor ETF (OMFS), we found that the implied analyst target price for the ETF based upon its underlying holdings is $46.00 per unit.

Rover Labs Provides Saliva-based COVID-19 Testing to New York City Public Schools
17 Jun, 2021 Yahoo! Finance

Rover Labs, a diagnostics technology leader in end-to-end saliva testing, is providing saliva-based COVID-19 testing to approximately 50 New York City public schools during a two-month pilot program that began on June 1 using technology developed by Fluidigm Corporation (Nasdaq:FLDM).

Next-Generation CyTOF XT Redefines Cytometry with Advances in Automation, Throughput, Time to Results and Total Cost of Ownership
25 May, 2021 FinancialContent

A New Platform to Simplify Deep Profiling of the Human Immune System

Imaging Mass Cytometry Utilized by Global Consortium Focused on New Precision Medicine Approaches for Treatment of Rheumatoid Arthritis
24 May, 2021 FinancialContent

FLAMIN-GO Project Seeks to Develop Organ-on-a-Chip Technology for Clinical Trials in Rheumatoid Arthritis Therapy

Fluidigm to Present at Upcoming Investor Conferences
14 May, 2021 FinancialContent
56 Biggest Movers From Yesterday
12 May, 2021 FinancialContent

Gainers Bridgford Foods Corporation (NASDAQ: BRID) shares surged 46.2% to close at $20.74 on Tuesday. Sequential Brands Group, ...

12 Health Care Stocks Moving In Tuesday's Intraday Session
11 May, 2021 FinancialContent

Gainers Applied DNA Sciences (NASDAQ:APDN) shares rose 27.71% to $7.42 during Tuesday's regular session. Trading ...

45 Stocks Moving In Tuesday's Mid-Day Session
11 May, 2021 FinancialContent

Gainers Sequential Brands Group, Inc. (NASDAQ: SQBG) surged 52.6% to $14.76 after dropping 11% on Monday. 3D Systems Corporation ...

Fluidigm Corporation (FLDM) is a NASDAQ Common Stock listed in , ,

970x250